No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4585-4586

  Minaguchi, Takeo ^a,b   Kanamori, Yasunobu ^a   Matsushima, Mieko ^a   Yoshikawa, Hiroyuki ^b   Taketani, Yuji ^b   Nakamura, Yusuke ^a,c  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; ONCOPROTEIN; PROLINE; PROTEIN P53; VIRUS DNA;

ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

CODON; FEMALE; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0032532316     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Yoshikawa, H., Kawana, T., Kitagawa, K., Mizuno, M., Yoshikura, H., and Iwamoto, A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res., 82: 524-531, 1991.
2. Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W., and Kurman, R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol., 79: 328-337, 1992.
3. Vousden, K. H., Doniger, J., DiPaolo, J. A., and Lowy, D. R. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res., 3: 167-175, 1988.
4. Barbosa, M. S., and Schlegel, R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene, 4: 1529-1532, 1989.
5. Crook, T., Morgenstern, J. P., Crawford, L., and Banks, L. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J., 8: 513-519, 1989.
6. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., and Schiller, J. T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J., 8: 3905-3910, 1989.
7. Munger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989.
8. Tanaka, A., Noda, T., Yajima, H., Hatanaka, M., and Ito, Y. Identification of a transforming gene of human papillomavirus type 16. J. Virol., 63: 1465-1469, 1989.
9. Halbert, C. L., Demers, G. W., and Galloway, D. A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol., 65: 473-478, 1991.
10. Watanabe, S., Kanda, T., and Yoshiike, K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol., 63: 965-969, 1989.
11. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
12. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
13. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
14. Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., and Enomoto, T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res., 52: 5323-5328, 1992.
15. Choo, K. B., and Chong, K. Y. Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology, 193: 1042-1046, 1993.
16. Paquette, R. L., Lee, Y. Y., Wilczynski, S. P., Karmakar, A., Kizaki, M., Miller, C. W., and Koeffler, H. P. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer (Phila.), 72: 1272-1280, 1993.
17. Alan, S., Miranda, T., Ann, K., Catherine, H., Daniela, G., Fiamma, M., Judith, B., Irene, M. L., Greg, M., and Lawrence, B. Role of p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (Lond.), 393: 229-234, 1998.
18. Yoshikawa, H., Matsukura, T., Yamamoto, E., Kawana, T., Mizuno, M., and Yoshiike, K. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas. Jpn. J. Cancer Res., 76: 667-671, 1985.
19. Nakagawa, S., Yoshikawa, H., Onda, T., Kawana, T., Iwamoto, A., and Taketani, Y. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer (Phila.), 78: 1935-1941, 1996.
20. Nagano, H., Yoshikawa, H., Kawana, T., Yokota, H., Taketani, Y., Igarashi, H., Yoshikura, H., and Iwamoto, A. Association of multiple human papillomavirus types with vulvar neoplasias. J. Obstet. Gynaecol. Res., 22: 1-8, 1996.
21. Helland, A., Holm, R., Kristensen, G., Kaern, J., Karlsen, F., Trope, C., Nesland, J. M., and Borresen, A. L. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J. Pathol., 171: 105-114, 1993.
22. Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B., and Klinger, H. P. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res., 56: 197-205, 1996.
23. Weber, J. L., and May, P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44: 388-396, 1989.
24. Jones, M. H., and Nakamura, Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer, 5: 89-90, 1992.
25. Oliphant, A. R., Wright, E. C., Swensen, J., Gruis, N. A., Goldgar, D., and Skolnick, M. H. Dinucleotide repeat polymorphism at the D17S513 locus. Nucleic Acids Res., 19: 4794, 1991.